MultiMedRx Review
Best for: patients comfortable with a $100 refundable consultation fee who want the option of brand-name GLP-1s (Ozempic, Wegovy, Zepbound) plus broader cardiometabolic care (Metformin, HRT, TRT) under one platform with disclosed legal entity and physical office addresses
MultiMedRx (multimedrx.com, legal entity 'MMRX MultiMedRx™ LLC') is a LegitScript-attested telehealth platform with physical offices in Newport Beach, CA and Reno, NV. Distinguishes itself by prominently featuring BRAND-NAME GLP-1s (Ozempic®, Wegovy®, Zepbound®) as primary offerings, plus a multi-modality menu (Metformin, Testosterone, HRT). Operates on a $100 fully-refundable consultation-fee model — uncommon among GLP-1 telehealth platforms which typically bundle the consultation. Pricing for medications themselves is intake-gated.
Medium confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
MultiMedRx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
MultiMedRx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Legal entity DISCLOSED verbatim in copyright footer: 'MMRX MultiMedRx™ LLC' — uncommon transparency vs peers who do not disclose entity name
- •Two physical addresses disclosed: Newport Beach, CA (Main Office, 1000 Quail St. #260) and Reno, NV (Telehealth Location, 401 Ryland St. #200-A)
- •LegitScript seal present
- •Prominently features BRAND-NAME GLP-1s (Ozempic, Wegovy, Zepbound) — uncommon vs the compounded-only segment that dominates the cluster
- •Multi-modality menu (Metformin, Testosterone, HRT) supports broader cardiometabolic care alongside GLP-1
- •$100 consultation fee is FULLY REFUNDABLE per the disclosed flow — risk-free intake
✗ Cons
- •Mounjaro and Foundayo NOT mentioned in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
- •Steady-state monthly pricing for any GLP-1 (brand or compounded) NOT disclosed publicly — gated behind the consultation
- •$100 consultation fee is a friction point — most peer telehealth platforms bundle consultation into the medication price
- •Per-state availability NOT enumerated; only CA + NV offices disclosed (the telehealth model presumably extends further but the specific state list is not published)
- •Specific compounded GLP-1 product line NOT explicitly addressed — site positioning emphasizes brand-name (verify scope during intake if compounded is desired)
- •Partner pharmacy / dispensing pathway NOT publicly disclosed
- •State of incorporation NOT disclosed
- •Compounded pricing tier (if any) NOT disclosed
Ready to start with MultiMedRx?
See current pricing and start your free consultation.
Sources & methodology
Our MultiMedRx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to MultiMedRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with MultiMedRx?
See current pricing and start your free consultation.